James P. Kelly
2014 - Vanda Pharmaceuticals
In 2014, James P. Kelly earned a total compensation of $1.2M as Executive Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Option Awards | $421,200 |
| Salary | $360,000 |
| Stock Awards | $245,400 |
| Other | $19,611 |
| Total | $1,226,211 |
Kelly received $421.2K in option awards, accounting for 34% of the total pay in 2014.
Kelly also received $180K in non-equity incentive plan, $360K in salary, $245.4K in stock awards and $19.6K in other compensation.
Rankings
In 2014, James P. Kelly's compensation ranked 6,669th out of 13,032 executives tracked by ExecPay. In other words, Kelly earned more than 48.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,669 out of 13,032 | 49th |
Division Manufacturing | 2,441 out of 4,965 | 51st |
Major group Chemicals And Allied Products | 821 out of 1,690 | 51st |
Industry group Drugs | 644 out of 1,369 | 53rd |
Industry Pharmaceutical Preparations | 491 out of 1,042 | 53rd |
Source: SEC filing on April 27, 2017.
Kelly's colleagues
We found two more compensation records of executives who worked with James P. Kelly at Vanda Pharmaceuticals in 2014.